Igal Moarof

Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial

Juan F. Iglesias, Olivier Müller, Dik Heg et al. · The Lancet · 2019 · 188 citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial

Thomas Pilgrim, Raffaele Piccolo, Dik Heg et al. · The Lancet · 2018 · 130 citations · Full text

Medicine, Cardiology, Cardiovascular Pharmacotherapy +15

Biodegradable- Versus Durable-Polymer Drug-Eluting Stents for STEMI

Thomas Pilgrim, Olivier Müller, Dik Heg et al. · JACC: Cardiovascular Interventions · 2021 · 57 citations · Full text

Medicine, Cardiology, Pharmacotherapy +12

Clinical Outcomes in High‐Gradient, Classical Low‐Flow, Low‐Gradient, and Paradoxical Low‐Flow, Low‐Gradient Aortic Stenosis After Transcatheter Aortic Valve Implantation: A Report From the SwissTAVI Registry

Max Wagener, Oliver Reuthebuch, Dik Heg et al. · Journal of the American Heart Association · 2023 · 45 citations · Full text

Medicine, Cardiology, Surgery +16

Giant Coronary Artery Aneurysm

Parham Eshtehardi, Stéphane Cook, Igal Moarof et al. · Circulation Cardiovascular Interventions · 2008 · 35 citations

Medicine, Cardiology, Internal Medicine +17